Shanghai-based biotech Shijian Bio has signed an exclusive option agreement with US firm ConjugateBio to license its EZWi-Fit ...

A San Francisco-based biopharma company developing a topical protein therapy for dystrophic epidermolysis bullosa (DEB).

US pharma giant Merck & Co has started building a $1 billion, 470,000-square-foot biologics center of excellence in ...

US biotech Transneural Therapeutics has named industry veteran Mark Demitrack as its chief research and development officer, ...

US biotech firm Stealth BioTherapeutics (OTCQB: MITO) is facing renewed uncertainty after the American medicines regulator ...

Chicago-based drugmaker AbbVie has announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), ...

Regulus Therapeutics (Nasdaq: RGLS) saw its shares leap 133% to $7.84 in pre-market activity this morning, on the news it has ...

Swiss generics and biosimilars major Sandoz (SIX: SDZ) has signed a global collaboration with Shanghai Henlius Biotech (HKEX: ...

Danish drugmaker Novo Nordisk has announced that it is expanding patient access to Wegovy (semaglutide) injection 2.4 mg in ...

In a recent study conducted by Navaneethan and colleagues and published in the International Society of Nephrology, the ...

Swiss generics and biosimilars major Sandoz (SIX: SDZ) today presented its net sales update for the first quarter of 2025.

The US Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets, also ...